EMPOWERING LEAD OPTIMIZATION Hager Biosciences is a start-up drug discovery organization based on innovative medicinal chemistry capabilities. The researchers work in the pre-clinical space, developing highly sought-after lead compounds for unmet medical needs and partnering with other companies to develop them further. We spoke to Dr. Bel Mekonnen, CEO of Hager Biosciences about his experiences with Reaxys and Reaxys Medicinal Chemistry. Dr.

Join for free to read